• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices

  • Print
  • Share
  • E-mail
-

GRN No. 1068

Lacto-N-tetraose

Intended Use: Intended for use as an ingredient in nonexempt infant formula for term infants at a level up to 0.8 g/L; in formula and other drinks for young children at up to 0.6 g/L; in foods for infants and young children at up to 5.0 g/kg; in sports and isotonic drinks, energy drinks, soft drinks, enhanced or fortified water, fruit-based ades, milk (unflavored and flavored), and buttermilk at up to 1.0 g/L; in meal replacement drinks at up to 2.0 g/L; in meal replacement bars at up to 20 g/kg; in cereal and granola bars at 10 g/kg; and in yogurt at up to 10 g/kg.
Basis: Scientific procedures
Notifier: Inbiose N.V.
Notifier Address: Technologiepark Zwijnaarde 82 - bus 41
B-9052 Gent
Belgium
GRAS Notice (releasable information): GRN 1068 with amendments (in PDF) (2 MB)
Date of closure: Jun 5, 2023
FDA's Letter: FDA has no questions (in PDF) (302 kB)
-
-